Compensated 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism
- 1 October 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 113 (2) , 226-232
- https://doi.org/10.1530/acta.0.1130226
Abstract
Thyroid function and thyroid gland volume, ultrasonically determined, were investigated in 27 hyperthyroid patients with solitary autonomous thyroid nodules before and during one year after 131I-treatment. Total thyroid volume decreased gradually from 40.9 ± 3.5 ml (mean ± sem) before treatment to 23.9 ± 1.8 ml (P < 0.001) at 3 months after 131I-treatment. No further change was observed. All but two patients received only one dose of 131I, and in spite of a significant decrease also of the non-adenoma side of the gland, none became hypothyroid. We conclude that 131I-therapy has an important place in the treatment of solitary autonomous thyroid nodules since all our patients became euthyroid within 3 months, only 2 of 27 patients needed more than one dose of 131I, no cases of hypothyroidism occurred, and thyroid volume was substantially decreased.This publication has 5 references indexed in Scilit:
- Successful Treatment of Solitary Toxic Thyroid Nodules with Relatively Low-Dose Iodine-131, with Low Prevalence of HypothyroidismAnnals of Internal Medicine, 1984
- Decreased Thyroid Gland Volume in Alcoholic Cirrhosis of the LiverJournal of Clinical Endocrinology & Metabolism, 1984
- 131I treatment of diffuse and nodular toxic goitre with or without antithyroid agentsActa Endocrinologica, 1982
- Radiation Dose in the Selection of 131I or Surgical Treatment for Toxic Thyroid AdenomaAnnals of Internal Medicine, 1978
- The Thyroid ScintigramRadiology, 1965